The Enterprise Value as of December 2025 (TTM) for Vanda Pharmaceuticals Inc. (VNDA) is 243.49M

According to Vanda Pharmaceuticals Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 243.49M. This represents a change of 22.20% compared to the average of 199.26M of the last 4 quarters.

Vanda Pharmaceuticals Inc. (VNDA) Historical Enterprise Value (quarterly & annually)

How has VNDA Enterprise Value performed in the past?

The mean historical Enterprise Value of Vanda Pharmaceuticals Inc. over the last ten years is 584.21M. The current 243.49M Enterprise Value has changed 4.07% with respect to the historical average. Over the past ten years (40 quarters), VNDA's Enterprise Value was at its highest in in the December 2018 quarter at 1.31B. The Enterprise Value was at its lowest in in the March 2023 quarter at 43.67M.

Vanda Pharmaceuticals Inc. (VNDA) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Vanda Pharmaceuticals Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Vanda Pharmaceuticals Inc. (VNDA) Average Enterprise Value

How has VNDA Enterprise Value performed in the past?

The current Enterprise Value of Vanda Pharmaceuticals Inc. (VNDA) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Vanda Pharmaceuticals Inc. (VNDA) Enterprise Value vs. Peers

How is VNDA’s Enterprise Value compared to its peers?

Vanda Pharmaceuticals Inc.’s Enterprise Value is greater than Achieve Life Sciences, Inc. (232.44M), less than Entrada Therapeutics, Inc. (347.42M), greater than Humacyte, Inc. (196.00M), greater than Voyager Therapeutics, Inc. (235.09M), greater than Atea Pharmaceuticals, Inc. (154.94M), greater than Arcturus Therapeutics Holdings Inc. (26.78M), less than Allogene Therapeutics, Inc. (362.93M), greater than Sagimet Biosciences Inc. (164.48M), greater than Immuneering Corporation (220.51M), less than Capricor Therapeutics, Inc. (1.14B),

Build a custom stock screener for Vanda Pharmaceuticals Inc. (VNDA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vanda Pharmaceuticals Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Vanda Pharmaceuticals Inc. (VNDA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Vanda Pharmaceuticals Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.